Case Reports and Reviews: Open Access

Introduction: Darier-Ferrand dermatofibrosarcoma (DFS) is a rare cutaneous mesenchymal tumour, the extent of tumour spread of which is often underestimated. It is distinguished by its local aggressiveness and its significant potential for recurrences, the prognosis of which is contingent on the quality of the patient's care. The management of localized forms is based on broad surgery, with meticulous evaluation of the margins. Treatment is based on surgery. Objective: To describe the management of frontal Darier-Ferrand dermatofibrosarcoma. Observation: This is a 23-year-old patient, with no medical or surgical history, who had consulted the Department of Stomatology and Maxillofacial Surgery of the CHUO for frontal swelling that had been evolving for two months. The clinical examination revealed a swelling resting on an indurated surface. A biopsy was performed under local anaesthesia, and the anatomo-pathological result was a Darier-Ferrand dermatofibrosarcoma. Subsequent to this, a broad excision with substance loss coverage (PDS) from a thin skin graft on the inner side of the thigh was performed. Conclusion: Dermato fibrosarcoma is a skin tumor whose frontal location is unusual and very rare. Surgery with significant margins for resection in healthy areas, covering the loss of substance by skin grafting is the solution.

Buttock augmentation has witnessed a surge in popularity as more individuals seek to enhance the size and shape of their buttocks. Traditional surgical methods, such as gluteal implants and fat transfer, have been widely employed to achieve this goal. However, the emergence of dermal fillers as a minimally invasive alternative has garnered significant attention in recent years. This article presents a comprehensive review of gluteal augmentation using dermal fillers, encompassing a detailed examination of the techniques involved, patient selection criteria, safety considerations, and potential outcomes. The objective of this review is to analyze existing literature and clinical experiences to offer valuable insights into the efficacy, longevity, and potential complications associated with gluteal augmentation using dermal fillers. A thorough exploration of the various techniques employed in this procedure will be provided, focusing on the strategic placement and volume of dermal fillers to achieve a fuller and more contoured appearance of the buttocks. Patient selection criteria will be thoroughly discussed, taking into consideration factors such as overall health, body type, and realistic expectations. By providing a clear understanding of suitable candidates, this review aims to assist patients and practitioners in making informed decisions regarding the appropriateness of gluteal augmentation with dermal fillers. Safety considerations will be emphasized throughout the article, as maintaining patient safety is of paramount importance. Potential risks and complications associated with dermal fillers for gluteal augmentation will be addressed, advocating for the necessity of seeking treatment from qualified and experienced practitioners. In addition, the article will delve into the outcomes and longevity of gluteal augmentation with dermal fillers. An analysis of existing data will be presented to ascertain the duration of results and potential need for touchup sessions over time.In conclusion, this comprehensive review intends to shed light on the intricacies of gluteal augmentation with dermal fillers, providing practitioners and patients with evidence-based insights. By presenting a balanced evaluation of techniques, safety considerations, and outcomes, this article aims to facilitate an informed and confident approach to buttock enhancement procedures.

Lung cancer is the most prevalent cancer in the developed world and the most common cause of cancer-related deaths. Metastasis to the gastrointestinal tract is relatively rare from any primary cancer, and particularly from lung cancer. The most common site of metastases of lung cancer is to the adrenals, liver, bone, and brain. Although metastasis to the gastrointestinal tract remains rare, it is under-diagnosed, and is likely to increase in frequency as patients with primary lung cancer live longer with their disease and therefore suffer more sequelae of advanced disease.